➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Moodys
Dow
Harvard Business School
Merck

Last Updated: April 19, 2021

DrugPatentWatch Database Preview

Drug Price Trends for IMATINIB MESYLATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for IMATINIB MESYLATE

Average Pharmacy Cost for IMATINIB MESYLATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
IMATINIB MESYLATE 400 MG TAB 00378-2246-93 4.20228 EACH 2021-02-17
IMATINIB MESYLATE 400 MG TAB 72485-0203-30 4.20228 EACH 2021-02-17
IMATINIB MESYLATE 400 MG TAB 00093-7630-56 4.20228 EACH 2021-02-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for IMATINIB MESYLATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
GLEEVEC 100MG TAB Novartis Pharmaceuticals Corporation 00078-0401-34 90 8291.92 92.13244 EACH 2020-09-01 - 2025-08-31 FSS
GLEEVEC 100MG TAB Novartis Pharmaceuticals Corporation 00078-0401-34 90 6262.53 69.58367 EACH 2021-01-01 - 2025-08-31 Big4
GLEEVEC 100MG TAB Novartis Pharmaceuticals Corporation 00078-0401-34 90 8291.92 92.13244 EACH 2021-01-01 - 2025-08-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Dow
AstraZeneca
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.